Literature DB >> 23452044

Detection of A/B toxin and isolation of Clostridium difficile and Clostridium perfringens from foals.

R O S Silva1, M G Ribeiro, M S Palhares, A S Borges, R P A Maranhão, M X Silva, T M Lucas, G Olivo, F C F Lobato.   

Abstract

REASONS FOR PERFORMING THE STUDY: Toxin detection and screening could contribute to knowledge of the transmission patterns, risk factors and epidemiology of Clostridium difficile and Clostridium perfringens.
OBJECTIVE: To isolate C. difficile and C. perfringens and to detect A/B toxins in faecal samples from diarrhoeic and nondiarrhoeic foals. STUDY
DESIGN: Cross-sectional observational study.
METHODS: A total of 153 samples from foals were collected: 139 samples from farms and 14 samples from diarrhoeic foals admitted to a veterinary hospital. The A/B toxins were detected by cytotoxicity assay. All suspected colonies of C. perfringens were subjected to polymerase chain reaction for detection of the major toxin genes (α, β, ε and ι) and for detection of β2-, NetB- and enterotoxin-encoding genes. Furthermore, C. difficile and C. perfringens isolates were evaluated for in vitro antimicrobial susceptibility.
RESULTS: Seven of 153 (4.6%) samples, all from diarrhoeic foals, were positive for C. difficile A/B toxin. Of these, 5 of 14 (35.7%) were from hospitalised foals, and only 2 of 63 (3.2%) diarrhoeic foal samples were from farms (P = 0.002). Clostridium perfringens was isolated from 31 (20.3%) foals, of which 21 of 76 (27.6%) were diarrhoeic and 10 of 76 (13.2%) were nondiarrhoeic, demonstrating a difference between these 2 groups (P = 0.045). Only 4 strains were positive for the β2-encoding gene (cpb2). All C. difficile and C. perfringens isolates were susceptible to metronidazole and vancomycin.
CONCLUSIONS: The present report highlights the need for laboratory diagnostics to differentiate C. difficile-associated infection in foals from other causes of diarrhoea to facilitate adequate antimicrobial therapy. POTENTIAL RELEVANCE: More studies are needed to clarify the role of C. perfringens as a primary agent of diarrhoea in foals.
© 2013 EVJ Ltd.

Entities:  

Keywords:  A/B toxins; colitis; horse; nosocomial diarrhoea

Mesh:

Substances:

Year:  2013        PMID: 23452044     DOI: 10.1111/evj.12046

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  14 in total

1.  Immunochromatographic test and ELISA for the detection of glutamate dehydrogenase (GDH) and A/B toxins as an alternative for the diagnosis of Clostridioides (Clostridium) difficile-associated diarrhea in foals and neonatal piglets.

Authors:  Carolina Pantuzza Ramos; Emily Oliveira Lopes; Carlos Augusto Oliveira Júnior; Amanda Nádia Diniz; Francisco Carlos Faria Lobato; Rodrigo Otávio Silveira Silva
Journal:  Braz J Microbiol       Date:  2020-05-03       Impact factor: 2.476

2.  Prevalence of netF-positive Clostridium perfringens in foals in southwestern Ontario.

Authors:  Abigail Finley; Iman Mehdizadeh Gohari; Valeria R Parreira; Miranda Abrahams; Henry R Staempfli; John F Prescott
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

3.  Clostridioides difficile and multi-drug-resistant staphylococci in free-living rodents and marsupials in parks of Belo Horizonte, Brazil.

Authors:  Jordana Almeida Santana; Salene Angelini Colombo; Brendhal Almeida Silva; Amanda Nádia Diniz; Lara Ribeiro de Almeida; Carlos Augusto Oliveira Junior; Francisco Carlos Faria Lobato; Giliane de Souza Trindade; Adriano Pereira Paglia; Rodrigo Otávio Silveira Silva
Journal:  Braz J Microbiol       Date:  2021-11-11       Impact factor: 2.476

4.  Fecal PCR testing for detection of Clostridium perfringens and Clostridioides difficile toxin genes and other pathogens in foals with diarrhea: 28 cases.

Authors:  K Gary Magdesian; Samantha Barnum; Nicola Pusterla
Journal:  J Vet Diagn Invest       Date:  2021-09-23       Impact factor: 1.569

Review 5.  NetF-producing Clostridium perfringens and its associated diseases in dogs and foals.

Authors:  Iman Mehdizadeh Gohari; Stefan Unterer; Ashley E Whitehead; John F Prescott
Journal:  J Vet Diagn Invest       Date:  2020-02-21       Impact factor: 1.279

6.  Detection of toxins A/B and isolation of Clostridium difficile and Clostridium perfringens from dogs in Minas Gerais, Brazil.

Authors:  Rodrigo Otávio Silveira Silva; Renata Lara Resende Santos; Prhiscylla Sadanã Pires; Luiz Carlos Pereira; Silvia Trindade Pereira; Marina Carvalho Duarte; Ronnie Antunes de Assis; Francisco Carlos Faria Lobato
Journal:  Braz J Microbiol       Date:  2013-03-26       Impact factor: 2.476

7.  Enteric Pathogens and Coinfections in Foals with and without Diarrhea.

Authors:  Giovane Olivo; Thays Mizuki Lucas; Alexandre Secorun Borges; Rodrigo Otávio Silveira Silva; Francisco Carlos Faria Lobato; Amanda Keller Siqueira; Domingos da Silva Leite; Paulo Eduardo Brandão; Fábio Gregori; José Paes de Oliveira-Filho; Shinji Takai; Márcio Garcia Ribeiro
Journal:  Biomed Res Int       Date:  2016-12-27       Impact factor: 3.411

8.  Clostridioides difficile infection in dogs with chronic-recurring diarrhea responsive to dietary changes.

Authors:  Rodrigo Otávio Silveira Silva; Carlos Augusto de Oliveira Júnior; Dominique S Blanc; Silvia Trindade Pereira; Mário Cesar Rennó de Araujo; Artur Vasconcelos; Francisco Carlos Faria Lobato
Journal:  Anaerobe       Date:  2018-04-03       Impact factor: 3.331

9.  Clostridium difficile ribotypes in humans and animals in Brazil.

Authors:  Rodrigo Otávio Silveira Silva; Maja Rupnik; Amanda Nádia Diniz; Eduardo Garcia Vilela; Francisco Carlos Faria Lobato
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-12-11       Impact factor: 2.743

10.  Clostridium perfringens type A netF and netE positive and Clostridium difficile co-infection in two adult dogs.

Authors:  Amanda Nádia Diniz; Rodrigo Otávio Silveira Silva; Carlos Augusto Oliveira Junior; Felipe Pierezan; Francisco Carlos Faria Lobato
Journal:  Anaerobe       Date:  2016-01-04       Impact factor: 3.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.